The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol

The coronavirus disease 2019 (COVID-19), a pneumonia caused by a novel coronavirus, was reported in December 2019. COVID-19 is highly contagious and has rapidly developed from a regional epidemic into a global pandemic. As yet, no effective drugs have been found to treat this virus. This study, an o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaoke, Yu, Kaijiang, Wang, Yongchen, Xu, Wanhai, Ma, Hongli, Hou, Yan, Li, Yue, Cai, Benzhi, Zhu, Liying, Zhang, Min, Hu, Xiaoli, Gao, Jingshu, Wang, Yu, Qin, Huichao, Zhao, Mingyan, Zhang, Yong, Li, Kang, Du, Zhimin, Yang, Baofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company. 2020
Materias:
Research Coronavirus Disease 2019—Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332434/
https://www.ncbi.nlm.nih.gov/pubmed/32837750
http://dx.doi.org/10.1016/j.eng.2020.06.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332434/
https://www.ncbi.nlm.nih.gov/pubmed/32837750
http://dx.doi.org/10.1016/j.eng.2020.06.011

Ejemplares similares